The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults
Open accessAbstract
Many physiologic differences between children and adults may result in age-related changes in pharmacokinetics and pharmacodynamics. Factors such as gastric pH and emptying time, intestinal transit time, immaturity of secretion and activity of bile and pancreatic fluid among other factors determine the oral bioavailability of pediatric and adult populations. Anatomical, physiological and biochemical characteristics in children also affect the bioavailability of other routes of administration. Key factors explaining differences in drug distribution between the pediatric population and adults are membrane permeability, plasma protein binding and total body water. As far as drug metabolism is concerned, important differences have been found in the pediatric population compared with adults both for phase I and phase II metabolic enzymes. Immaturity of glomerular filtration, renal tubular secretion and tubular reabsorption at birth and their maturation determine the different excretion of drugs in the pediatric population compared to adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
Kearns, G. L., Abdel-Rahman, S. M., Alander, S. W., Blowey, D. L., Leeder, J. S., & Kauffman, R. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035092 · Cited by 2,421
Lacroix, D., Sonnier, M., Moncion, A., Cheron, G., & Cresteil, T. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00625.x · Cited by 539
Human renal function maturation: a quantitative description using weight and postmenstrual age
Rhodin, M. M., Anderson, B. J., Peters, A. M., Coulthard, M. G., Wilkins, B., Cole, M., Chatelut, E., Grubb, A., Veal, G. J., Keir, M. J., et al. (2009) · Pediatric Nephrology · doi:10.1007/s00467-008-0997-5 · Cited by 497
Clinical Pharmacokinetics of Levetiracetam
Patsalos, P. N. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443110-00002 · Cited by 473
Role of transport proteins in drug absorption, distribution and excretion
Ayrton, A., & Morgan, P. (2001) · Xenobiotica · doi:10.1080/00498250110060969 · Cited by 421
Developmental patterns of renal functional maturation compared in the human neonate
Arant, B. S. (1978) · The Journal of Pediatrics · doi:10.1016/s0022-3476(78)80133-4 · Cited by 418
Bartelink, I. H., Rademaker, C. M. A., Schobben, A. F. A. M., & van den Anker, J. N. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645110-00003 · Cited by 418
Clinical Pharmacokinetics of Rifampicin
Acocella, G. (1978) · Clinical Pharmacokinetics · doi:10.2165/00003088-197803020-00002 · Cited by 405
Morselli, P. L., Franco-Morselli, R., & Bossi, L. (1980) · Clinical Pharmacokinetics · doi:10.2165/00003088-198005060-00001 · Cited by 387
Ontogeny of Hepatic and Renal Systemic Clearance Pathways in Infants: Part I
Alcorn, J., & McNamara, P. J. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241120-00003 · Cited by 333
Developmental Expression of Human Hepatic CYP2C9 and CYP2C19
Koukouritaki, S. B., Manro, J. R., Marsh, S. A., Stevens, J. C., Rettie, A. E., McCarver, D. G., & Hines, R. N. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060137 · Cited by 325
The Pharmacokinetics of Propofol in Children Using Three Different Data Analysis Approaches
Kataria, B. K., Ved, S. A., Nicodemus, H. F., Hoy, G. R., Lea, D., Dubois, M. Y., Mandema, J. W., & Shafer, S. L. (1994) · Anesthesiology · doi:10.1097/00000542-199401000-00018 · Cited by 322
Björkman, S. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02225.x · Cited by 244
Drug metabolism and disposition in children
Strolin Benedetti, M., & Baltes, E. L. (2003) · Fundamental & Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00140.x · Cited by 182
Ontogeny of Hepatic and Renal Systemic Clearance Pathways in Infants: Part II
Alcorn, J., & McNamara, P. J. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241130-00005 · Cited by 182
Treluyer, J.-M., Gueret, G., Cheron, G., Sonnier, M., & Cresteil, T. (1997) · Pharmacogenetics · doi:10.1097/00008571-199712000-00002 · Cited by 178
Benedetti, M. S., Whomsley, R., & Baltes, E. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.3.447 · Cited by 155
Alternative Routes of Drug Administration—Advantages and Disadvantages (Subject Review)
(1997) · PEDIATRICS · doi:10.1542/peds.100.1.143 · Cited by 154
Maturation of caffeine elimination in infancy
Aranda, J. V., Collinge, J. M., Zinman, R., & Watters, G. (1979) · Archives of Disease in Childhood · doi:10.1136/adc.54.12.946 · Cited by 148 · cited 1×
“Clearance of caffeine is decreased in the neonate reaching the adult rate of elimination by 5-6 months of age [45].”
Backgroundvan Lingen, R. A., Deinum, J. T., Quak, J. M. E., Kuizenga, A. J., van Dam, J. G., Anand, K. J. S., Tibboel, D., & Okken, A. (1999) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.80.1.f59 · Cited by 147
Morphine metabolism in children.
Choonara, I., McKay, P., Hain, R. D., & Rane, A. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03548.x · Cited by 147
Optimizing Pediatric Dosing: A Developmental Pharmacologic Approach
Anderson, G. D., & Lynn, A. M. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.680 · Cited by 146
Pharmacokinetic observations of phenytoin disposition in the newborn and young infant.
Loughnan, P. M., Greenwald, A., Purton, W. W., Aranda, J. V., Watters, G. V., & Neims, A. H. (1977) · Archives of Disease in Childhood · doi:10.1136/adc.52.4.302 · Cited by 122
Boucher, F. D., Modlin, J. F., Weller, S., Ruff, A., Mirochnick, M. H., Pelton, S. I., Wilfert, C. M., McKinney, R. E., Crain, M. J., Elkins, M., et al. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83507-3 · Cited by 111
Pharmacokinetics and metabolism of oral midazolam in preterm infants
de Wildt, S. N., Kearns, G. L., Hop, W. C. J., Murry, D. J., Abdel‐Rahman, S. M., & van den Anker, J. N. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01223.x · Cited by 106
Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.
Cazeneuve, C., Pons, G., Rey, E., Tréluyer, J., Cresteil, T., Thiroux, G., d’Athis, P., & Olivé, G. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb05706.x · Cited by 106
Borland, M. L., Bergesio, R., Pascoe, E. M., et al. (2005) · Burns · doi:10.1016/j.burns.2005.05.001 · Cited by 105
Pediatric Pharmacokinetic Data: Implications for Environmental Risk Assessment for Children
Ginsberg, G., Hattis, D. B., Miller, R. K., & Sonawane, B. R. (2004) · PEDIATRICS · doi:10.1542/peds.113.s3.973 · Cited by 96
Effect of maturation on drug disposition in pediatric patients.
Stewart, C. F., & Hampton, E. M. (1987) · PubMed · Cited by 95
Hunt, A., Joel, S., Dick, G., & Goldman, A. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70326-4 · Cited by 94
McCracken, G. H., Ginsburg, C. M., Clahsen, J. C., & Thomas, M. L. (1978) · PEDIATRICS · doi:10.1542/peds.62.5.738 · Cited by 91
Drug metabolism in the paediatric population and in the elderly
Benedetti, M. S., Whomsley, R., & Canning, M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.011 · Cited by 81
A Review of Developmental Aspects of Cytochrome P450
Oesterheld, J. R. (1998) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1998.8.161 · Cited by 80
Bile salt metabolism in the first year of life.
Heubi, J. E., Balistreri, W. F., & Fj, S. (1982) · PubMed · Cited by 76
Clinical Pharmacokinetics of Intranasal Sumatriptan
Fuseau, E., Petricoul, O., Moore, K. H., Barrow, A., & Ibbotson, T. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241110-00002 · Cited by 69 · cited 1×
“Some drugs that have been tested intranasally in children are midazolam, fentanyl, butorphanol, ketamine, sufentanil, corticosteroids, antihistamines, sumatriptan and desmopressin [27-31].”
BackgroundFluoxetine Pharmacokinetics in Pediatric Patients
Wilens, T. E., Cohen, L., Biederman, J., Abrams, A., Neft, D., Faird, N., & Sinha, V. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200212000-00006 · Cited by 64
Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex
Kornhuber, J., Konradi, C. L., Mack-Burkhardt, F., Riederer, P. F., Heinsen, H., & Beckmann, H. (1989) · Brain Research · doi:10.1016/0006-8993(89)91136-0 · Cited by 63
Boehm, G., Braun, W., Moro, G., & MINOLI, I. (2009) · Biology of the Neonate · doi:10.1159/000244419 · Cited by 59
Aman, M. G., Vinks, A. A. T. M. M., Remmerie, B. M. M., Mannaert, E., Ramadan, Y., Masty, J. K., Lindsay, R. L., & Malone, K. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.026 · Cited by 51
Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children
Tran, A., Rey, E., Pons, G., Pariente-Khayat, A., D'Athis, P., Sallerin, V., & Dupont, C. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.122472 · Cited by 47
Pharmacokinetics of Anti-Infective Agents in Paediatric Patients
Butler, D. R., Kuhn, R. J., & Chandler, M. H. H. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199426050-00005 · Cited by 41
Theophylline Toxicokinetics in Premature Newborns
Lowry, J. A., Jarrett, R. V., Wasserman, G. S., Pettett, G., & Kauffman, R. E. (2001) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.155.8.934 · Cited by 35
Cohen‐Wolkowiez, M., Moran, C., Benjamin, D. K., & Smith, P. B. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283321ccc · Cited by 35
Transdermal delivery of theophylline to premature infants using a hydrogel disc system.
Cartwright, R., Cartlidge, P., Rutter, N., et al. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03676.x · Cited by 34
Phenytoin Age-Dose-Concentration Relationship in Children
Suzuki, Y., Mimaki, T., Cox, S., Koepke, J., & Hayes, J. (1994) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199404000-00006 · Cited by 28
Intranasal Drug Delivery for Children with Acute Illness
Goldman, R. D. (2006) · Current Drug Therapy · doi:10.2174/157488506775268470 · Cited by 22
Sheth, K. K., Cook, C. K., Philpot, E. E., Prillaman, B. A., Witham, L. A., Faris, M. A., Klein, K. C., & RICKARD, K. A. (2004) · PubMed · Cited by 22
The Effect of Age on Drug Metabolism
de Wildt, S. N., Johnson, T. N., & Choonara, I. (2003) · Paediatric and Perinatal Drug Therapy · doi:10.1185/146300903322012013 · Cited by 21
[Intranasal opioids for acute pain].
Simón, C. A., Bartomeu, M. R., Pérez, A. R., & Baena, A. F. (2006) · PubMed · Cited by 10
Cited by
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
Millar, S. A., Stone, N. L., Yates, A. S., & O'Sullivan, S. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01365 · Cited by 560
Namaste, S. M., Rohner, F., Huang, J., Bhushan, N. L., Flores-Ayala, R., Kupka, R., Mei, Z., Rawat, R., Williams, A. M., Raiten, D. J., et al. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.141762 · Cited by 366
Pediatric Drug Formulations: A Review of Challenges and Progress
Ivanovska, V., Rademaker, C. M. A., van Dijk, L., & Mantel-Teeuwisse, A. K. (2014) · Pediatrics · doi:10.1542/peds.2013-3225 · Cited by 324
The clinical toxicology of caffeine: A review and case study
Willson, C. (2018) · Toxicology Reports · doi:10.1016/j.toxrep.2018.11.002 · Cited by 289
Postural orthostatic tachycardia syndrome in children and adolescents
Boris, J. R. (2018) · Autonomic Neuroscience · doi:10.1016/j.autneu.2018.05.004 · Cited by 58
Metadata
- Authors
- Fernandez, E., Perez, R., Hernandez, A., Tejada, P., Arteta, M., & Ramos, J. T.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2011-02-07
- Volume
- 3
- Issue
- 1
- Pages
- 53-72
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W2170341168
- Cited by
- 370
- References
- 49
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.